Antimelanoma activity of apoptogenic carbonyl scavengers

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 2, 2006, Pages 805-814

  Wondrak, Georg T ^a,b   Jacobson, Myron K ^a   Jacobson, Elaine L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; ANTINEOPLASTIC AGENT; CARBONYL SCAVENGER; CYCLOSPORIN A; HEAT SHOCK PROTEIN 27; MITOCHONDRIAL PERMEABILITY TRANSITION PORE PROTEIN; PENICILLAMINE; PHENYLGLYOXAL; PROTEIN; SCAVENGER; STAUROSPORINE; UNCLASSIFIED DRUG;

ADDUCTION; AMINO ACID SEQUENCE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG SPECIFICITY; DRUG STRUCTURE; GLYCOLYSIS; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; FIBROBLASTS; FREE RADICAL SCAVENGERS; GLYOXAL; HUMANS; INTRACELLULAR MEMBRANES; KERATINOCYTES; MELANOMA; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 31144445226     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.094953     Document Type: Article

References (41)

1. Abe R, Shimizu T, Sugawara H, Watanabe H, Nakamura H, Choei H, Sasaki N, Yamagishi S, Takeuchi M, and Shimizu H (2004) Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions. J Investig Dermatol 122:461-467.
2. Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, and Baynes JW (1997) N-ε-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324:565-570.
3. Atamna H, Paler-Martinez A, and Ames BN (2000) N-t-butyl hydroxylamine, a hydrolysis product of α-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J Biol Chem 275:6741-6748.
4. Baynes JW and Thorpe SR (2000) Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708-1716.
5. Beisswenger PJ, Howell SK, Touchette AD, Lal S, and Szwergold BS (1999) Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 48:198-202.
6. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, Gurbuxani S, Arrigo AP, Kroemer G, Solary E, et al. (2000) Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2:645-652.
7. Dang CV and Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24:68-72.
8. Don AS and Hogg PJ (2004) Mitochondria as cancer drug targets. Trends Mol Med 10:372-378.
9. Duan S, Hajek P, Lin C, Shin SK, Attardi G, and Chomyn A (2003) Mitochondrial outer membrane permeability change and hypersensitivity to digitonin early in staurosporine-induced apoptosis. J Biol Chem 278:1346-1353.
10. Edelstein D and Brownlee M (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41:26-29.
11. Eriksson O, Fontaine E, and Bernardi P (1998) Chemical modification of arginines by 2,3-butanedione and phenylglyoxal causes closure of the mitochondrial permeability transition pore. J Biol Chem 273:12669-12674.
12. Eriksson O, Fontaine E, Petronilli V, and Bernardi P (1997) Inhibition of the mitochondrial cyclosporin A-sensitive permeability transition pore by the arginine reagent phenylglyoxal. FEBS Lett 409:361-364.
13. Green DR and Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science (Wash DC) 305:626-629.
14. Havre PA, O'Reilly S, McCormick JJ, and Brash DE (2002) Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine. Cancer Res 62:1443-1449.
15. Hipkiss AR, Brownson C, Bertani MF, Ruiz E, and Ferro A (2002) Reaction of carnosine with aged proteins: another protective process? Ann NY Acad Sci 959:285-294.
16. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, and Rauvala H (2002) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 62:4805-4811.
17. Johans M, Milanesi E, Franck M, Johans C, Liobikas J, Panagiotaki M, Greci L, Principato G, Kinnunen PK, Bernardi P, et al. (2005) Modification of permeability transition pore arginine(s) by phenylglyoxal derivatives in isolated mitochondria and mammalian cells. Structure-function relationship of arginine ligands. J Biol Chem 280:12130-12136.
18. Jung ME and Gervay J (1991) gem-Dialkyl effect in the intramolecular Diels-Alder reaction of 2-furfuryl methyl fumarates: the reactive rotamer effect, the enthalpic basis for acceleration and evidence for a polar transition state. J Am Chem Soc 113:224-232.
19. Kawase M, Tada M, Akagi S, and Ohmori S (1996) Changes in concentrations of methylglyoxal, D-lactate and glyoxalase activities in liver and plasma of rats fed a 3′-methyl-4-dimethylaminoazobenzene-rich diet. Res Exp Med 196:251-259.
20. Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kuraoka K, Ito R, Yokozaki H, and Yasui W (2002) Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 196:163-170.
21. Lehman TD and Ortwerth BJ (2001) Inhibitors of advanced glycation end product-associated protein cross-linking. Biochim Biophys Acta 1535:110-119.
22. Miller DL (1949) Synthesis of D,L-penicillamine from N-acetyl-D,L- penicillamine, in The Chemistry of Penicillin, Princeton University Press, Princeton, NJ.
23. Ocker M, Herold C, Ganslmayer M, Hahn EG, and Schuppan D (2003) The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro. Int J Cancer 107:453-459.
24. Qin JZ, Ziffra J, Stennett L, Bodner B, Bonish BK, Chaturvedi V, Bennett F, Pollock PM, Trent JM, Hendrix MJ, et al. (2005) Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Res 65:6282-6293.
25. Roberts MJ, Wondrak GT, Cervantes-Laurean D, Jacobson MK, and Jacobson EL (2003) DNA damage by carbonyl stress in human skin cells. Mutat Res 522:45-56.
26. Ruggiero-Lopez D, Lecomte M, Moinet G, Patereau G, Lagarde M, and Wiernsperger N (1999) Reaction of metformin with dicarbonyl compounds. Possible implications in the inhibition of advanced glycation end product formation. Biochem Pharm 58:1765-1773.
27. Sakamoto H, Mashima T, Yamamoto K, and Tsuruo T (2002) Modulation of heat-shock protein 27 (Hsp27) anti-apoptotic activity by methylglyoxal modification. J Biol Chem 277:45770-45775.
28. Sander CS, Hamm F, Elsner P, and Thiele JJ (2003) Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br J Dermatol 148:913-922.
29. Scarlett JL, Sheard PW, Hughes G, Ledgerwood EC, Ku HH, and Murphy MP (2000) Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 475:267-272.
30. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, and Brownlee M (1998) Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation end product formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Investig 101:1142-1147.
31. Shipanova IN, Glomb MA, and Nagaraj RH (1997) Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 344:29-36.
32. Speer O, Morkunaite-Haimi S, Liobikas J, Franck M, Hensbo L, Linder MD, Kinnunen PK, Wallimann T, and Eriksson O (2003) Rapid suppression of mitochondrial permeability transition by methylglyoxal. Role of reversible arginine modification. J Biol Chem 278:34757-34763.
33. Tafani M, Minchenko DA, Serroni A, and Farber JL (2001) Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res 61:2459-2466.
34. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature (Lond) 405:354-360.
35. Thornalley PJ (1995) Advances in glyoxalase research. Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione and methylglyoxal-modified protein binding and endocytosis by the advanced glycation end product receptor. Crit Rev Oncol Hematol 20:99-128.
36. Thornalley PJ (2005) Dicarbonyl intermediates in the Maillard reaction. Ann NY Acad Sci 1043:111-117.
37. Thornalley P, Yurek-George A, and Argirov OK (2000) Kinetics and mechanism of the reaction of aminoguanidine with the α-oxoaldehydes glyoxal, methylglyoxal and 3-deoxyglucosone under physiological conditions. Biochem Pharmacol 60:55-65.
38. Ulrich P and Cerami A (2001) Protein glycation, diabetes and aging. Recent Prog Horm Res 56:1-21.
39. Winterbourn CC and Metodiewa D (1999) Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic Biol Med 27:322-328.
40. Wondrak GT, Cervantes-Laurean D, Roberts MJ, Qasem JG, Kim M, Jacobson EL, and Jacobson MK (2002) Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem Pharmacol 63:361-373.
41. Wondrak GT, Jacobson MK, and Jacobson EL (2005) An emerging molecular target in melanoma: cellular carbonyl stress and the inhibition of mitochondrial survival pathways by carbonyl scavenger agents. Curr Cancer Ther Rev 1:271-276.